N/A
N=6
Study of the Ability of Betaine Hydrochloride to Increase Stomach Acid in Healthy Volunteers
Pharmacodynamic
Bottom Line
View on ClinicalTrials.gov: NCT01237353 ↗Enrolled (actual)
6
Serious AEs
0.0%
Results posted
Jul 2013
Primary outcome: Primary: Change in Gastric pH After Administration of Betaine Hydrochloride (HCl) — 4.54 units on a scale
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- betaine hydrochloride (Dietary_supplement); Rabeprazole (Drug)
- Age
- Adult · 18+ yrs
- Sex
- All
- Sponsor
- University of California, San Francisco
- Primary completion
- Jul 2011
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Change in Gastric pH After Administration of Betaine Hydrochloride (HCl) |
4.54 | — |
| SECONDARY Duration of Gastric pH Status |
6.3; 72.5; 76.8 | — |
Summary
In this study the investigators will test a nutritional supplement called betaine hydrochloride to see if it can temporarily increase the stomach acid in healthy volunteers who have decreased stomach acid because they take a medicine called rabeprazole.
Eligibility Criteria
Inclusion Criteria
- Healthy adult with no active medical problems or significant chronic diseases as determined by the study doctor based on history, physical exam;
- BMI between 18.5 - 35 kg/m2;
- Taking no medications 2 weeks before and during the study enrollment, including drugs of abuse, prescription or OTC medications (except acetaminophen);
- Subjects must be able to maintain adequate birth control during the study independent of hormonal contraceptive use;
- Be able to provide written informed consent and comply with requirements of the study;
- Avoid eating grapefruit and drinking grapefruit juice from 7 days before the first study day until completion of the entire study;
- Abstinence from alcoholic beverages, caffeinated beverages and orange juice from 6pm the night before a study day until completion of that study day;
- Fast from food and beverages at least 8 hours prior to the study day;
- Be able to read, speak and understand English
Exclusion Criteria
- Subjects with a history of gastrointestinal disease including gastroesophageal reflux disease, gastritis, peptic ulcer disease or dyspepsia.
- Subjects with a fasting gastric pH of > 4 (i.e. hypochlorhydria)
- Subjects with history of dysphagia, achalasia, or difficulty swallowing capsules, tablets or pills.
- Subjects on prescription or chronic over-the counter medications (including hormonal contraceptives);
- Subjects with known allergy to study interventions;
- Subjects who smoke tobacco;
- Subjects with ongoing alcohol or illegal drug use;
- Subjects who are pregnant, lactating or attempting to conceive;
- Subjects unable to maintain adequate birth control during the study;
- Subjects unable to follow protocol instructions or protocol criteria.
Data sourced from ClinicalTrials.gov (NCT01237353). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.